Steve MacMillan, Hologic chairman, president and CEO, is stepping down when the company's go-private transaction with Blackstone and TPG closes, expected on or about April 7.
MacMillan, who joined the firm in December 2013, has led the medical technology company for more than 12 years. During his tenure, Hologic's revenue increased 65%, its share price increased 241%, and its workforce increased by more than 1,500 people, it said.
MacMillan's successor has not yet been named but is expected to be announced when the transaction closes.
